SCHEMBL22011819

SCHEMBL22011819

CCCCCc1ccc(CCc2cc3oc4cc(CCc5ccc(CCC)c(F)c5)c(F)c(F)c4c3c(F)c2F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.37
ALOX5 P09917 3/20 0.34
MEN1 O00255 2/20 0.34
HTT P42858 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
TYR P14679 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TLR8 Q9NR97 6/20 0.32
HTR2A P28223 2/20 0.32
HTR2C P28335 1/20 0.32
GPR55 Q9Y2T6 1/20 0.31
RARB P10826 2/20 0.31
RARA P10276 1/20 0.31
RARG P13631 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010983 0.86 ALDH1A1 (0.38) HTTTP53CYP3A4TSHRHTR2A
SCHEMBL22011800 0.85 HTT (0.37) ALOX5MEN1HTTKMT2ATP53
SCHEMBL20828855 0.81 ALDH1A1 (0.40) ALOX5MEN1HTTKMT2ATP53
SCHEMBL22011234 0.81 CTSL (0.38) ALOX5MEN1HTTKMT2ATP53
SCHEMBL9399139 0.80 TYR (0.49) S1PR1ALOX5MEN1HTTKMT2A
SCHEMBL22011103 0.79 RARB (0.42) MEN1KMT2ATP53CYP3A4MAPT
SCHEMBL9399529 0.78 HTR2A (0.48) S1PR1ALOX5MEN1HTTKMT2A
SCHEMBL22011795 0.78 ALDH1A1 (0.38) ALOX5MEN1HTTKMT2AMAPT
SCHEMBL18351445 0.78 S1PR1 (0.37) S1PR1ALOX5MEN1HTTKMT2A
SCHEMBL9398851 0.77 HTR2A (0.52) S1PR1TP53CYP3A4HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 S1PR1 1710/4885ALOX5 1263/4885MEN1 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.